SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-23-003016
Filing Date
2023-08-30
Accepted
2023-08-30 07:15:24
Documents
37
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K zk2330231.htm   iXBRL 6-K 17366
2 PRESS RELEASE DATED AUGUST 30, 2023 exhibit_1.htm EX-99 387968
3 REGISTRANT'S CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS exhibit_2.htm   iXBRL EX-99 567018
4 OPERATING AND FINANCIAL REVIEW AS OF JUNE 30, 2023 exhibit_3.htm EX-99 214419
10 GRAPHIC image00001.jpg GRAPHIC 2824
  Complete submission text file 0001178913-23-003016.txt   2800091

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE blrx-20230630.xsd EX-101.SCH 36029
6 XBRL CALCULATION FILE blrx-20230630_cal.xml EX-101.CAL 30945
7 XBRL DEFINITION FILE blrx-20230630_def.xml EX-101.DEF 47326
8 XBRL LABEL FILE blrx-20230630_lab.xml EX-101.LAB 283194
9 XBRL PRESENTATION FILE blrx-20230630_pre.xml EX-101.PRE 116450
31 EXTRACTED XBRL INSTANCE DOCUMENT zk2330231_htm.xml XML 216547
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 231223685
SIC: 2834 Pharmaceutical Preparations